|
MyCo_1059
| Human | Human | Pneumocystis | Pneumocystis jirovecii | Bronchoalveolar lavage fluid neutrophils | NA | Prognostic | Unspecified | 76 | Republic of Korea | Pneumocystis | Bronchoalveolar lavage fluid (BALF) | Body fluid | Cell-based Assay | Ex-vivo |
25673796
|
|
MyCo_1067
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus spp. | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | None | Germany | Aspergillus | Serum | Body fluid | Immunoassay | ELISA |
22324986
|
|
MyCo_1122
| Human | Human | Cryptococcosis (Cryptococcus Infection) | Cryptococcus spp. | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | None | USA | Cryptococcus | Cerebrospinal fluid (CSF) | Body fluid | Hybrid Methods | Lateral flow + Chemiluminescence |
35611348
|
|
MyCo_1139
| Human | Human | Trichosporonosis | Trichosporon spp. | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | 16–78 | Canada | Trichosporon | Serum | Body fluid | Immunoassay | ELISA |
22832213
|
|
MyCo_1168
| Human | Human | Pneumocystis | Pneumocystis carinii | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | 54.4 ± 4.69 | Japan | Pneumocystis | Bronchoalveolar lavage fluid (BALF) | Body fluid | Immunoassay | ELISA |
16173245
|
|
MyCo_1524
| Animal | Dog | Coccidioidomycosis | Coccidioides spp. | C-reactive protein | Protein | Prognostic | Unspecified | 38 ± 15.6 | Multi-Location | Coccidioides | Serum | Body fluid | Immunoassay | ELISA |
38901453
|
|
MyCo_1610
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus flavus | Glactomannan | Protein | Prognostic | Unspecified | None | India | Aspergillus | Serum | Body fluid | Immunoassay | ELISA |
23508427
|
|
MyCo_1614
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Glactomannan | Protein | Prognostic | Unspecified | None | India | Aspergillus | Serum | Body fluid | Immunoassay | ELISA |
23508427
|
|
MyCo_1702
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus spp. | Pentraxin-3 (4.29 ng/mL ) | Protein | Prognostic | Unspecified | None | China | Aspergillus | Bronchoalveolar lavage fluid (BALF) | Body fluid | Immunoassay | ELISA |
39878524
|
|
MyCo_1703
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus spp. | Pentraxin-3 (7.11 ng/mL) | Protein | Prognostic | Unspecified | None | China | Aspergillus | Plasma | Body fluid | Immunoassay | ELISA |
39878524
|
|
MyCo_1774
| Human | Human | Candidiasis (Candida Infection) | Candida spp. | C-reactive protein | Protein | Prognostic | Unspecified | None | Israel | Candida | Serum | Body fluid | Immunoassay | ELISA |
15085896
|
|
MyCo_1837
| Human | Human | Candidiasis (Candida Infection) | Candida spp. | Interleukin-6 | Protein | Prognostic | Unspecified | None | Israel | Candida | Serum | Body fluid | Immunoassay | ELISA |
15085896
|
|
MyCo_1898
| Human | Human | Candidiasis (Candida Infection) | Candida spp. | Mid-regional proadrenomedullin | Protein | Prognostic | Unspecified | Jan-18 | Greece | Candida | Blood | Body fluid | Immunoassay | ELISA |
38028393
|
|
MyCo_1938
| Human | Human | Candidiasis (Candida Infection) | Candida spp. | Serum amyloid A | Protein | Prognostic | Unspecified | None | Israel | Candida | Serum | Body fluid | Immunoassay | ELISA |
15085896
|
|
MyCo_1939
| Human | Human | Candidiasis (Candida Infection) | Candida albicans | CD14 | Protein | Prognostic | Unspecified | None | Germany | Candida | Serum | Body fluid | Immunoassay | ELISA |
11035437
|
|
MyCo_1940
| Human | Human | Candidiasis (Candida Infection) | Candida albicans | Soluble E-selectin | Protein | Prognostic | Unspecified | None | Germany | Candida | Serum | Body fluid | Immunoassay | ELISA |
11035437
|
|
MyCo_1941
| Human | Human | Candidiasis (Candida Infection) | Candida albicans | Soluble ICAM-1 | Protein | Prognostic | Unspecified | None | Germany | Candida | Serum | Body fluid | Immunoassay | ELISA |
11035437
|
|
MyCo_1955
| Human | Human | Candidiasis (Candida Infection) | Candida spp. | WBC Counts | Protein | Prognostic | Unspecified | None | Israel | Candida | Serum | Body fluid | Immunoassay | ELISA |
15085896
|
|
MyCo_1965
| Human | Human | Coccidioidomycosis | Coccidioides immitis | recombinant proline-rich antigen | Protein | Prognostic | Unspecified | None | USA | Coccidioides | Serum | Body fluid | Immunoassay | ELISA |
9868663
|
|
MyCo_1978
| Human | Human | Cryptococcosis (Cryptococcus Infection) | Cryptococcus spp. | Cryptococcal antigen | Protein | Prognostic | Unspecified | None | USA | Cryptococcus | Cerebrospinal fluid (CSF) | Body fluid | Immunoassay | ELISA |
35611348
|
|
MyCo_2033
| Human | Human | Histoplasmosis (Histoplasma Infection) | Histoplasma capsulatum | 1281–1283(220) | Gene | Prognostic | Unspecified | None | Mexico | Histoplasma | Serum | Body fluid | Immunoassay | ELISA |
27726064
|
|
MyCo_2042
| Animal | Mice | Histoplasmosis (Histoplasma Infection) | Histoplasma capsulatum | β-Glucan Induced Lipid bodies (LBs) | Protein | Prognostic | Unspecified | None | Brazil | Histoplasma | Bronchoalveolar lavage fluid (BALF) | Body fluid | Immunoassay | ELISA |
19299700
|
|
MyCo_2043
| Human | Human | Histoplasmosis (Histoplasma Infection) | Histoplasma capsulatum | β-Glucan Induced Lipid bodies (LBs) | Protein | Prognostic | Unspecified | None | Brazil | Histoplasma | Human PBMC | Body fluid | Immunoassay | ELISA |
19299700
|
|
MyCo_2076
| Human | Human | Paracoccidioidomycosis | Paracoccidioides brasiliensis | Immunoglobulin E | Protein | Prognostic | Multiple organs | 33-82 and 11-24 | Brazil | Paracoccidioides | Serum | Body fluid | Immunoassay | ELISA |
19684969
|
|
MyCo_2077
| Human | Human | Paracoccidioidomycosis | Paracoccidioides brasiliensis | Immunoglobulin G | Protein | Prognostic | Multiple organs | 33-82 and 11-23 | Brazil | Paracoccidioides | Serum | Body fluid | Immunoassay | ELISA |
19684969
|
|
MyCo_2141
| Human | Human | Pneumocystis | Pneumocystis carinii | Interleukin-8 | Protein | Prognostic | Unspecified | None | USA | Pneumocystis | Bronchoalveolar lavage fluid (BALF) | Body fluid | Immunoassay | ELISA |
7690822
|
|
MyCo_2142
| Human | Human | Pneumocystis | Pneumocystis carinii | Interleukin-8 | Protein | Prognostic | Unspecified | None | Denmark | Pneumocystis | Bronchoalveolar lavage fluid (BALF) | Body fluid | Immunoassay | ELISA |
7697231
|
|
MyCo_2307
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus spp. | anti-β-glucan | Protein | Prognostic | Unspecified | None | Japan | Aspergillus | Plasma | Body fluid | Immunoassay | ELISA |
19190977
|
|
MyCo_2308
| Human | Human | Carinii Pneumonitis | Unclassified | anti-β-glucan | Protein | Prognostic | Unspecified | None | Japan | Unclassified | Plasma | Body fluid | Immunoassay | ELISA |
19190977
|
|
MyCo_2468
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus spp. | Galactomannan | Protein | Prognostic | Unspecified | None | India | Aspergillus | Serum | Body fluid | Immunoassay | ELISA |
29684057
|
|
MyCo_2572
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Galactomannan | Protein | Prognostic | Lungs | 58-72 | France | Aspergillus | Serum | Body fluid | Immunoassay | ELISA |
34985983
|
|
MyCo_2902
| Human | Human | Cryptococcosis (Cryptococcus Infection) | Cryptococcus spp. | Cryptococcal antigen | Protein | Prognostic | Unspecified | None | USA | Cryptococcus | Cerebrospinal fluid (CSF) | Body fluid | Immunoassay | Lateral flow |
35611348
|
|
MyCo_2995
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | 1-3-beta-D-Glucan | Protein | Prognostic | Lungs | 58-72 | France | Aspergillus | Serum | Body fluid | Immunoassay | Chemiluminescence |
34985983
|
|
MyCo_3007
| Human | Human | Candidiasis (Candida Infection) | Candida albicans | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | 19–91 | USA | Candida | Serum | Body fluid | Immunoassay | Chemiluminescence |
22573851
|
|
MyCo_3008
| Human | Human | Candidiasis (Candida Infection) | Candida glabrata | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | 19–91 | USA | Candida | Serum | Body fluid | Immunoassay | Chemiluminescence |
22573851
|
|
MyCo_3009
| Human | Human | Candidiasis (Candida Infection) | Candida guilliermondii | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | 19–91 | USA | Candida | Serum | Body fluid | Immunoassay | Chemiluminescence |
22573851
|
|
MyCo_3010
| Human | Human | Candidiasis (Candida Infection) | Candida kefyr | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | 19–91 | USA | Candida | Serum | Body fluid | Immunoassay | Chemiluminescence |
22573851
|
|
MyCo_3011
| Human | Human | Candidiasis (Candida Infection) | Candida krusei | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | 19–91 | USA | Candida | Serum | Body fluid | Immunoassay | Chemiluminescence |
22573851
|
|
MyCo_3012
| Human | Human | Candidiasis (Candida Infection) | Candida lusitaniae | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | 19–91 | USA | Candida | Serum | Body fluid | Immunoassay | Chemiluminescence |
22573851
|
|
MyCo_3013
| Human | Human | Candidiasis (Candida Infection) | Candida parapsilosis | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | 19–91 | USA | Candida | Serum | Body fluid | Immunoassay | Chemiluminescence |
22573851
|
|
MyCo_3015
| Human | Human | Candidiasis (Candida Infection) | Candida tropicalis | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | 19–91 | USA | Candida | Serum | Body fluid | Immunoassay | Chemiluminescence |
22573851
|
|
MyCo_3192
| Human | Human | Candidiasis (Candida Infection) | Candida albicans | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | 35–62 | Italy | Candida | Serum | Body fluid | Immunoassay | Chemiluminescence |
38997712
|
|
MyCo_3193
| Human | Human | Candidiasis (Candida Infection) | Candida glabrata | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | 35–62 | Italy | Candida | Serum | Body fluid | Immunoassay | Chemiluminescence |
38997712
|
|
MyCo_3194
| Human | Human | Candidiasis (Candida Infection) | Candida parapsilosis | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | 35–62 | Italy | Candida | Serum | Body fluid | Immunoassay | Chemiluminescence |
38997712
|
|
MyCo_3471
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Fractional exhaled nitric oxide | Volatile | Prognostic | Unspecified | 54.6±16.5 | China | Aspergillus | Exhaled air | None | Biochemical Assay | Clinical chemistry |
38777120
|
|
MyCo_3485
| Human | Human | Candidiasis (Candida Infection) | Candida glabrata | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | None | Spain | Candida | Serum | Body fluid | Immunoassay | Chemiluminescence |
31680136
|
|
MyCo_3494
| Human | Human | Candidiasis (Candida Infection) | Candida spp. | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | None | USA | Candida | Plasma | Body fluid | Immunoassay | Chemiluminescence |
34128840
|
|
MyCo_3696
| Human | Human | Candidiasis (Candida Infection) | Candida albicans | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | None | China | Candida | Serum | Body fluid | Biochemical Assay | Colorimetric assay |
25874376
|
|
MyCo_3697
| Human | Human | Candidiasis (Candida Infection) | Candida famata | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | None | China | Candida | Serum | Body fluid | Biochemical Assay | Colorimetric assay |
25874376
|
|
MyCo_3698
| Human | Human | Candidiasis (Candida Infection) | Candida guilliermondii | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | None | China | Candida | Serum | Body fluid | Biochemical Assay | Colorimetric assay |
25874376
|
|
MyCo_3699
| Human | Human | Candidiasis (Candida Infection) | Candida krusei | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | None | China | Candida | Serum | Body fluid | Biochemical Assay | Colorimetric assay |
25874376
|
|
MyCo_3700
| Human | Human | Candidiasis (Candida Infection) | Candida parapsilosis | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | None | China | Candida | Serum | Body fluid | Biochemical Assay | Colorimetric assay |
25874376
|
|
MyCo_3723
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus spp. | Galactomannan | Protein | Prognostic | Unspecified | None | USA | Aspergillus | Serum | Body fluid | Immunoassay | Lateral flow |
35611348
|
|
MyCo_3724
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus spp. | Galactomannan | Protein | Prognostic | Unspecified | 57–73 | None | Aspergillus | Bronchoalveolar lavage fluid (BALF) | Body fluid | Immunoassay | Lateral flow |
35321555
|
|
MyCo_3768
| Animal | Dog | coccidioidomycosis | Coccidioides spp. | Haptoglobin | Protein | Prognostic | Unspecified | 38 ± 15.6 | Multi-Location | Coccidioides | Serum | Body fluid | Mass Spectrometry | HPLC |
38901453
|
|
MyCo_3786
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | forced expiratory volume after 1 minute | NA | Prognostic | Unspecified | 39-66 | UK | Aspergillus | NA | None | Instrument-based | Imaging |
32077238
|
|
MyCo_3870
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Aspergillus fumigatus-specific Immunoglobulin E (> 9.88 kUA/L) | Protein | Prognostic | Unspecified | 71 | China | Aspergillus | Serum | Body fluid | Immunoassay | ELISA |
40065361
|
|
MyCo_4016
| Human | Human | Alternaria Infection | Alternaria alternata | Immunoglobulin E | Protein | Prognostic | Unspecified | 18-35 | Ireland | Alternaria | Serum | Body fluid | Immunoassay | Chemiluminescence |
11127497
|
|
MyCo_4019
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus spp. | Eosinophils‐to‐Leukocyte Ratio | NA | Prognostic | Unspecified | 72.6 ± 10.9 | Israel | Aspergillus | Blood | Body fluid | Immunoassay | Chemiluminescence |
38263617
|
|
MyCo_4020
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus spp. | Eosinophils‐to‐Neutrophils Ratio | NA | Prognostic | Unspecified | 72.6 ± 10.9 | Israel | Aspergillus | Blood | Body fluid | Immunoassay | Chemiluminescence |
38263617
|
|
MyCo_4022
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Immunoglobulin E | Protein | Prognostic | Unspecified | 18-35 | Ireland | Aspergillus | Serum | Body fluid | Immunoassay | Chemiluminescence |
11127497
|
|
MyCo_4039
| Human | Human | Candidiasis (Candida Infection) | Candida spp. | Eosinophils‐to‐Leukocyte Ratio | NA | Prognostic | Unspecified | 72.6 ± 10.9 | Israel | Candida | Blood | Body fluid | Immunoassay | Chemiluminescence |
38263617
|
|
MyCo_4040
| Human | Human | Candidiasis (Candida Infection) | Candida spp. | Eosinophils‐to‐Neutrophils Ratio | NA | Prognostic | Unspecified | 72.6 ± 10.9 | Israel | Candida | Blood | Body fluid | Immunoassay | Chemiluminescence |
38263617
|
|
MyCo_4043
| Human | Human | Candidiasis (Candida Infection) | Candida albicans | Immunoglobulin E | Protein | Prognostic | Unspecified | 18-35 | Ireland | Candida | Serum | Body fluid | Immunoassay | Chemiluminescence |
11127497
|
|
MyCo_4077
| Human | Human | Cladosporium Infection | Cladosporidium herbarum | Immunoglobulin E | Protein | Prognostic | Unspecified | 18-35 | Ireland | Cladosporium | Serum | Body fluid | Immunoassay | Chemiluminescence |
11127497
|
|
MyCo_4084
| Human | Human | Curvularia Infection | Curvularia lunata | Immunoglobulin E | Protein | Prognostic | Unspecified | 18-35 | Ireland | Curvularia | Serum | Body fluid | Immunoassay | Chemiluminescence |
11127497
|
|
MyCo_4085
| Human | Human | Helminthosporium Infection | Helminthosporium halodes | Immunoglobulin E | Protein | Prognostic | Unspecified | 18-35 | Ireland | Helminthosporium | Serum | Body fluid | Immunoassay | Chemiluminescence |
11127497
|
|
MyCo_4101
| Human | Human | Mucor Infection | Mucor spp. | Eosinophils‐to‐Leukocyte Ratio | NA | Prognostic | Unspecified | 72.6 ± 10.9 | Israel | Mucor | Blood | Body fluid | Immunoassay | Chemiluminescence |
38263617
|
|
MyCo_4102
| Human | Human | Mucor Infection | Mucor spp. | Eosinophils‐to‐Neutrophils Ratio | NA | Prognostic | Unspecified | 72.6 ± 10.9 | Israel | Mucor | Blood | Body fluid | Immunoassay | Chemiluminescence |
38263617
|
|
MyCo_4103
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus spp. | Immunoglobulin E | Protein | Prognostic | Unspecified | 18-35 | Ireland | Aspergillus | Serum | Body fluid | Immunoassay | Chemiluminescence |
11127497
|
|
MyCo_4104
| Human | Human | Penicillium Infection | Penicillium notatum | Immunoglobulin E | Protein | Prognostic | Unspecified | 18-35 | Ireland | Penicillium | Serum | Body fluid | Immunoassay | Chemiluminescence |
11127497
|
|
MyCo_4120
| Human | Human | Mucormycosis | Rhizopus nigricans | Immunoglobulin E | Protein | Prognostic | Unspecified | 18-35 | Ireland | Rhizopus | Serum | Body fluid | Immunoassay | Chemiluminescence |
11127497
|
|
MyCo_4388
| Human | Human | Pneumocystis | Pneumocystis jirovecii | KL-6 | Protein | Prognostic | Unspecified | 37-86 | Japan | Pneumocystis | Serum | Body fluid | Immunoassay | ELISA |
28567422
|
|
MyCo_4991
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Serum disaccharide | Protein | Prognostic | Unspecified | None | France | Aspergillus | Serum | Body fluid | Mass Spectrometry | MALDI |
27605710
|
|
MyCo_4992
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Serum disaccharide | Protein | Prognostic | Unspecified | None | France | Aspergillus | Serum | Body fluid | Mass Spectrometry | MALDI |
27605710
|
|
MyCo_5312
| Human | Human | Candidiasis (Candida Infection) | Candida spp. | Pancreatic stone protein | Protein | Prognostic | Unspecified | Jan-18 | Greece | Candida | Plasma | Body fluid | Immunoassay | Latex agglutination |
38028393
|
|
MyCo_5421
| Human | Human | Histoplasmosis (Histoplasma Infection) | Histoplasma capsulatum | 1281–1283(220) | Gene | Prognostic | Unspecified | None | Mexico | Histoplasma | Extracted DNA | Macromolecule | Molecular Methods | PCR |
27726064
|
|
MyCo_5452
| Human | Human | Cryptococcosis (Cryptococcus Infection) | Cryptococcus spp. | 1-3-beta-D-Glucan | Protein | Prognostic | Unspecified | None | USA | Cryptococcus | Cerebrospinal fluid (CSF) | Body fluid | Molecular Methods | PCR |
35611348
|
|
MyCo_5480
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus flavus | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Aspergillus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5481
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus flavus | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Aspergillus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5482
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus flavus | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Aspergillus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5483
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus flavus | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Aspergillus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5484
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Aspergillus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5485
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Aspergillus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5486
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Aspergillus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5487
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Aspergillus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5488
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus niger | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Aspergillus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5489
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus niger | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Aspergillus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5490
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus niger | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Aspergillus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5491
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus niger | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Aspergillus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5492
| Human | Human | Mucormycosis | Mucor spp. | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Mucor | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5493
| Human | Human | Mucormycosis | Mucor spp. | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Mucor | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5494
| Human | Human | Mucormycosis | Mucor spp. | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Mucor | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5495
| Human | Human | Mucormycosis | Mucor spp. | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Mucor | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5496
| Human | Human | Mucormycosis | Rhizomucor spp. | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Rhizomucor | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5497
| Human | Human | Mucormycosis | Rhizomucor spp. | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Rhizomucor | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5498
| Human | Human | Mucormycosis | Rhizomucor spp. | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Rhizomucor | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5499
| Human | Human | Mucormycosis | Rhizomucor spp. | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Rhizomucor | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5500
| Human | Human | Mucormycosis | Rhizopus spp. | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Rhizopus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5501
| Human | Human | Mucormycosis | Rhizopus spp. | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Rhizopus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5502
| Human | Human | Mucormycosis | Rhizopus spp. | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Rhizopus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5503
| Human | Human | Mucormycosis | Rhizopus spp. | Internal Transcribed Spacer | Gene | Prognostic | Unspecified | None | USA | Rhizopus | Plasma | Body fluid | Molecular Methods | PCR |
38602412
|
|
MyCo_5655
| Human | Human | Cryptococcosis (Cryptococcus Infection) | Cryptococcus neoformans | exo-miR-4449 | miRNA | Prognostic | Unspecified | None | China | Cryptococcus | Cell Line | Cell Line | Molecular Methods | PCR |
37995394
|
|
MyCo_5718
| Animal | Mice | Pneumocystis | Pneumocystis spp. | MiR-150 | miRNA | Prognostic | Unspecified | None | China | Pneumocystis | Extracted Tissue | Biopsy | Molecular Methods | PCR |
38471665
|
|
MyCo_5719
| Human | Human | Pneumocystis | Pneumocystis spp. | MiR-150 | miRNA | Prognostic | Unspecified | 36-69 | China | Pneumocystis | Extracted Tissue | Biopsy | Molecular Methods | PCR |
38471665
|
|
MyCo_5954
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Interleukin-6 | Protein | Prognostic | Unspecified | None | Austria | Aspergillus | Serum | Body fluid | Immunoassay | Multiplex immunoassays |
31428097
|
|
MyCo_5955
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Interleukin-6 | Protein | Prognostic | Unspecified | None | Austria | Aspergillus | Bronchoalveolar lavage fluid (BALF) | Body fluid | Immunoassay | Multiplex immunoassays |
31428097
|
|
MyCo_5956
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Interleukin-8 | Protein | Prognostic | Unspecified | None | Austria | Aspergillus | Serum | Body fluid | Immunoassay | Multiplex immunoassays |
31428097
|
|
MyCo_5957
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Interleukin-8 | Protein | Prognostic | Unspecified | None | Austria | Aspergillus | Bronchoalveolar lavage fluid (BALF) | Body fluid | Immunoassay | Multiplex immunoassays |
31428097
|
|
MyCo_6430
| Human | Human | Pneumocystis | Pneumocystis carinii | Carcinoembryonic Antigen | Protein | Prognostic | Unspecified | None | France | Pneumocystis | Serum | Body fluid | Immunoassay | Chemiluminescence |
1509235
|
|
MyCo_6438
| Human | Human | Cryptococcosis (Cryptococcus Infection) | Cryptococcus spp. | Cryptococcus antigen | Protein | Prognostic | Unspecified | None | Colombia | Cryptococcus | Cerebrospinal fluid (CSF) | Body fluid | Immunoassay | Lateral flow |
39657327
|
|
MyCo_6439
| Human | Human | Cryptococcosis (Cryptococcus Infection) | Cryptococcus spp. | Cryptococcus antigen | Protein | Prognostic | Unspecified | None | Colombia | Cryptococcus | Serum | Body fluid | Immunoassay | Lateral flow |
39657327
|
|
MyCo_6440
| Human | Human | Cryptococcosis (Cryptococcus Infection) | Cryptococcus spp. | Cryptococcus antigen | Protein | Prognostic | Unspecified | None | Colombia | Cryptococcus | Cerebrospinal fluid (CSF) | Body fluid | Immunoassay | Lateral flow |
39657327
|
|
MyCo_6441
| Human | Human | Cryptococcosis (Cryptococcus Infection) | Cryptococcus spp. | Cryptococcus antigen | Protein | Prognostic | Unspecified | None | Colombia | Cryptococcus | Serum | Body fluid | Immunoassay | Lateral flow |
39657327
|
|
MyCo_6442
| Human | Human | Cryptococcosis (Cryptococcus Infection) | Cryptococcus spp. | Cryptococcus antigen | Protein | Prognostic | Unspecified | None | Colombia | Cryptococcus | Cerebrospinal fluid (CSF) | Body fluid | Immunoassay | Lateral flow |
39657327
|
|
MyCo_6443
| Human | Human | Cryptococcosis (Cryptococcus Infection) | Cryptococcus spp. | Cryptococcus antigen | Protein | Prognostic | Unspecified | None | Colombia | Cryptococcus | Serum | Body fluid | Immunoassay | Lateral flow |
39657327
|
|
MyCo_6444
| Human | Human | Cryptococcosis (Cryptococcus Infection) | Cryptococcus spp. | Cryptococcus antigen | Protein | Prognostic | Unspecified | None | Colombia | Cryptococcus | Cerebrospinal fluid (CSF) | Body fluid | Immunoassay | Lateral flow |
39657327
|
|
MyCo_6445
| Human | Human | Cryptococcosis (Cryptococcus Infection) | Cryptococcus spp. | Cryptococcus antigen | Protein | Prognostic | Unspecified | None | Colombia | Cryptococcus | Serum | Body fluid | Immunoassay | Lateral flow |
39657327
|
|
MyCo_6446
| Human | Human | Cryptococcosis (Cryptococcus Infection) | Cryptococcus spp. | Cryptococcus antigen | Protein | Prognostic | Unspecified | None | Colombia | Cryptococcus | Cerebrospinal fluid (CSF) | Body fluid | Immunoassay | Lateral flow |
39657327
|
|
MyCo_6447
| Human | Human | Cryptococcosis (Cryptococcus Infection) | Cryptococcus spp. | Cryptococcus antigen | Protein | Prognostic | Unspecified | None | Colombia | Cryptococcus | Serum | Body fluid | Immunoassay | Lateral flow |
39657327
|
|
MyCo_6521
| Human | Human | Alternaria Infection | Alternaria alternata | Antigen skin prick test | Antigen | Prognostic | Unspecified | 18-35 | Ireland | Alternaria | Serum | Body fluid | Cell-based Assay | Cell-activation |
11127497
|
|
MyCo_6522
| Human | Human | Aspergillosis (Aspergillus Infection) | Aspergillus fumigatus | Antigen skin prick test | Antigen | Prognostic | Unspecified | 18-35 | Ireland | Aspergillus | Serum | Body fluid | Cell-based Assay | Cell-activation |
11127497
|
|
MyCo_6523
| Human | Human | Candidiasis (Candida Infection) | Candida albicans | Antigen skin prick test | Antigen | Prognostic | Unspecified | 18-35 | Ireland | Candida | Serum | Body fluid | Cell-based Assay | Cell-activation |
11127497
|
|
MyCo_6524
| Human | Human | Cladosporium Infection | Cladosporidium herbarum | Antigen skin prick test | Antigen | Prognostic | Unspecified | 18-35 | Ireland | Cladosporium | Serum | Body fluid | Cell-based Assay | Cell-activation |
11127497
|
|
MyCo_6525
| Human | Human | Curvularia Infection | Curvularia lunata | Antigen skin prick test | Antigen | Prognostic | Unspecified | 18-35 | Ireland | Curvularia | Serum | Body fluid | Cell-based Assay | Cell-activation |
11127497
|
|
MyCo_6526
| Human | Human | Helminthosporium Infection | Helminthosporium halodes | Antigen skin prick test | Antigen | Prognostic | Unspecified | 18-35 | Ireland | Helminthosporium | Serum | Body fluid | Cell-based Assay | Cell-activation |
11127497
|
|
MyCo_6527
| Human | Human | Mucormycosis | Mucor mucado | Antigen skin prick test | Antigen | Prognostic | Unspecified | 18-35 | Ireland | Mucor | Serum | Body fluid | Cell-based Assay | Cell-activation |
11127497
|
|
MyCo_6528
| Human | Human | Penicillium Infection | Penicillium notatum | Antigen skin prick test | Antigen | Prognostic | Unspecified | 18-35 | Ireland | Penicillium | Serum | Body fluid | Cell-based Assay | Cell-activation |
11127497
|
|
MyCo_6529
| Human | Human | Mucormycosis | Rhizopus nigricans | Antigen skin prick test | Antigen | Prognostic | Unspecified | 18-35 | Ireland | Rhizopus | Serum | Body fluid | Cell-based Assay | Cell-activation |
11127497
|
